Tg(SNCA*A30P)192Rwm
Transgene Detail
|
|
| Symbol: |
Tg(SNCA*A30P)192Rwm |
| Name: |
transgene insertion 192, Richard Wade-Martins |
| MGI ID: |
MGI:5543905 |
| Synonyms: |
SNCA-A30P |
| Transgene: |
Tg(SNCA*A30P)192Rwm Location: unknown Genetic Position: Chr15, Syntenic
|
| Alliance: |
Tg(SNCA*A30P)192Rwm page
|
|
|
|
| Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(SNCA*A30P)192Rwm expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
SNCA (6622) |
|
|
|
| |
|
Mutation details: This transgene consists of a 135 kb BAC clone, PAC-27 M07, containing the complete 111 kb human SNCA genomic DNA locus with the Parkinson Disease-associated A30P mutation, flanked by 18 kb of 5' and 6 kb of 3' genomic DNA sequence which includes the promoter. Western blot analysis confirmed expression of the human protein in the brain. Line 192 contains a single copy insertion in chromosome 15.
(J:201961)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:201961 Taylor TN, et al., Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P alpha-synuclein BAC transgenic mouse. Neurobiol Dis. 2013 Oct 10;62C:193-207 |
| All: |
2 reference(s) |
|